Autopsy report · NCT01347645
Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer
Cause of deathFunding or business
“The study was terminated by the Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI”
Life of this trial
- Registered 5 months before it started.
- Ran for about 3 years 9 months before it stopped.
- 82 participants enrolled.
- Results were posted on the registry 7 years 5 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1, Phase 2
- Sponsor
- Eisai Inc.
- Sponsor type
- Industry
- Conditions
- Colon Cancer; Rectal Cancer
- Interventions
- FOLFIRI; E7820
- Participants
- 82
- Sites
- 38
- Countries
- Argentina, Australia, Brazil, Russia, Ukraine, United States
Trials that died the same way
- A Study of an Ad26.RSV.preF-based Regimen in the Prevention of Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)-Confirmed Respiratory Syncytial Virus (RSV)-Mediated Lower Respiratory Tract Disease in Adults Aged 65 Years and Older
“The study was terminated early by the sponsor due to strategic reprioritization reasons.” - Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy
“This study was terminated by the Sponsor.” - Trial of Erlotinib in Patients With JAK-2 V617F Positive Polycythemia Vera
“The study was terminated by the sponsor” - A Study Of Duloxetine Hydrochloride Hard Gelatinous Capsule Compared To Cymbalta Under Fed Conditions
“This study has been cancelled prior to FSFV due to business reasons” - A Study to Assess Recurrence of Actinic Keratosis in Participants Treated With Methyl Aminolevulinate Hydrochloride Cream or Vehicle Cream Who Achieved Complete Response to Treated Lesions in Earlier Study
“The study was terminated early as per Sponsor's decision”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.